A patient with recalcitrant oral pemphigus vulgaris successfully treated with a biologic drug- Rituximab
Pemphigus vulgaris (PV) is a chronic autoimmune blistering disease affecting mucous membranes and the skin. Rituximab (RTX), a monoclonal antibody against CD20, has been approved by FDA for the treatment of adults with moderate to severe PV. A 42-year-old Indian woman, previously diagnosed with oral...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Online |
| Taal: | Engels |
| Gepubliceerd in: |
International Association for Dental Research (Nigeria Division)
2019
|
| Online toegang: | https://ajoh.oauife.edu.ng/index.php/ajoh/article/view/41 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|
Wees de eerste die reageert!